Metropolitan Life Insurance CO Precision Biosciences Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.96 - $7.76 $41,070 - $107,670	-13,875 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$7.4 - $11.66 $102,675 - $161,782	13,875 New	13,875 $102,000
Q4 2021 Mar 30, 2023	BUY	$7.4 - $11.66 $5,217 - $8,220	705 Added 5.35%	13,875 $102,000
Q4 2021 Feb 15, 2022	BUY	$7.4 - $11.66 $5,217 - $8,220	705 Added 5.35%	13,875 $103,000
Q3 2021 Jun 21, 2023	BUY	$9.18 - $14.15 $120,900 - $186,355	13,170 New	13,170 $151,000
Q3 2021 Mar 30, 2023	SELL	$9.18 - $14.15 $11,181 - $17,234	-1,218 Reduced 8.47%	13,170 $151,000
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $11,181 - $17,234	-1,218 Reduced 8.47%	13,170 $152,000
Q2 2021 Mar 30, 2023	BUY	$8.07 - $12.52 $15,680 - $24,326	1,943 Added 15.61%	14,388 $180,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $116,014 - $179,987	14,376 Added 119800.0%	14,388 $180,000
Q1 2021 Jun 26, 2023	BUY	$8.57 - $15.79 $106,653 - $196,506	12,445 New	12,445 $129 Million
Q1 2021 Mar 30, 2023	BUY	$8.57 - $15.79 $10,026 - $18,474	1,170 Added 10.38%	12,445 $128,000
Q1 2021 May 14, 2021	SELL	$8.57 - $15.79 $96,523 - $177,842	-11,263 Reduced 99.89%	12 $129,000
Q4 2020 Jun 22, 2023	BUY	$5.98 - $12.47 $67,424 - $140,599	11,275 New	11,275 $94,000
Q4 2020 Mar 30, 2023	SELL	$5.98 - $12.47 $11,230 - $23,418	-1,878 Reduced 14.28%	11,275 $94,000
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $11,230 - $23,418	-1,878 Reduced 14.28%	11,275 $94,000
Q3 2020 Jun 26, 2023	BUY	$4.65 - $8.73 $61,161 - $114,825	13,153 New	13,153 $81,000
Q3 2020 Mar 30, 2023	BUY	$4.65 - $8.73 $130 - $244	28 Added 0.21%	13,153 $81,000
Q3 2020 Nov 13, 2020	BUY	$4.65 - $8.73 $130 - $244	28 Added 0.21%	13,153 $81,000
Q2 2020 Jun 26, 2023	BUY	$4.66 - $8.7 $61,162 - $114,187	13,125 New	13,125 $109,000
Q2 2020 Mar 30, 2023	BUY	$4.66 - $8.7 $3,522 - $6,577	756 Added 6.11%	13,125 $109,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $3,522 - $6,577	756 Added 6.11%	13,125 $109,000
Q1 2020 Jul 12, 2023	BUY	$5.05 - $15.01 $62,463 - $185,658	12,369 New	12,369 $74,000
Q1 2020 Mar 30, 2023	BUY	$5.05 - $15.01 $131 - $390	26 Added 0.21%	12,369 $74,000
Q1 2020 May 15, 2020	BUY	$5.05 - $15.01 $131 - $390	26 Added 0.21%	12,369 $75,000
Q4 2019 Jul 12, 2023	BUY	$6.32 - $19.66 $78,007 - $242,663	12,343 New	12,343 $171,000
Q4 2019 Mar 30, 2023	BUY	$6.32 - $19.66 $78,007 - $242,663	12,343 New	12,343 $171,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $78,007 - $242,663	12,343 New	12,343 $171,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.62 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.03 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.95 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.12 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$773,470
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account